OMA Guidelines Bundle

Obesity Pharmacological Management - OMA Obesity 2021

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, Enjoy!

Issue link:

Contents of this Issue


Page 21 of 21

Disclaimer is pocket guide attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is pocket guide should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Abbreviations CLA, conjugated linoleic acid; DEA, Drug Enforcement Administration; EGCG, epigallocatechin gallate; FDA, Food and Drug Administration; HAART, highly active antiretroviral therapies; HCP, healthcare personnel; HDS, herbal and dietary supplements; HGC, human chorionic gonadotropin; MAO, monoamine oxidase; OTC, over-the-counter; PPA, phenylpropanolamine; USP, United States Pharmacopeia Source Bays HE, McCarthy W, Burridge K, Tondt J, Karjoo S, Christensen S, Ng J, Golden A, Davisson L, Richardson L. Obesity Algorithm eBook, presented by the Obesity Medicine Association. 2021. (Accessed = January 2021) OMAOBEPS02212f 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 FAX: 407.878.7611 Copyright © 2021 All rights reserved Obesity Medicine Association 7173 S. Havana St #600-130 Centennial, CO 80112 TEL: 303.770.2526

Articles in this issue

Links on this page

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity Pharmacological Management - OMA Obesity 2021